Circulating Interleukin-11 Across Allergic and Non-Allergic Airway Disease Phenotypes: A Single-Center Exploratory Study
Life · 07.09.2026 · 16 (9) · 1497
DOI: 10.3390/life16091497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 07.09.2026. Verfasst von Corina Porr und 7 weiteren Autor:innen. Beteiligte Einrichtung: Allergology Department, Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Interleukin-11 (IL-11) is implicated in epithelial dysfunction, fibroblast activation, tissue remodeling, and chronic inflammatory responses; however, the clinical value of circulating IL-11 in airway disease remains uncertain. This single-center retrospective exploratory observational study included 88 adults: 31 with allergic rhinitis, 15 with non-allergic asthma, 22 with allergic asthma associated with allergic rhinitis, and 20 healthy controls. Serum IL-11 concentrations were measured using a quantitative sandwich enzyme-linked immunosorbent assay. Between-group differences were assessed using the Kruskal–Wallis test followed by Holm-adjusted pairwise Mann–Whitney U tests. Associations with disease-specific ordinal clinical categories were evaluated using Spearman rank correlation, with GINA treatment Steps used for asthma phenotypes and ARIA severity categories for allergic rhinitis. Median IL-11 concentrations were 62.01 pg/mL in non-allergic asthma, 78.87 pg/mL in allergic rhinitis, 61.92 pg/mL in allergic asthma associated with allergic rhinitis, and 95.46 pg/mL in healthy controls. The primary global comparison was not statistically significant (H = 5.667, p = 0.129), and no pairwise comparison remained significant after Holm correction. Six measurements (6.8%) were below the assay detection limit; replacing these values with 4.0 pg/mL in a sensitivity analysis did not materially alter the global result (H = 5.671, p = 0.129). Serum IL-11 was not significantly associated with GINA treatment step in non-allergic asthma (rho = −0.170, p = 0.544) or allergic asthma associated with allergic rhinitis (rho = 0.052, p = 0.818), nor with ARIA severity category in allergic rhinitis (rho = 0.046, p = 0.805). In an exploratory analysis adjusted for age, sex, body-mass category, and current smoking status, IL-11 concentrations were lower in each clinical phenotype relative to healthy controls; given the modest group sizes and baseline imbalance, this finding was considered hypothesis-generating. Overall, the primary analysis did not demonstrate significant differences in circulating IL-11 across study groups, and serum IL-11 was not associated with disease-specific ordinal clinical categories. These findings do not support the use of a single serum IL-11 measurement as a stand-alone biomarker of airway disease phenotype or clinical category in this cohort and warrant confirmation in larger, prospectively characterized cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Allergology Department, Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania.
- Allergology Department, County Clinical Emergency Hospital Sibiu, Bulevardul Corneliu Coposu 2-4, 550245 Sibiu, Romania.
- Department of Paediatrics, Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania.
- Department of Radiology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Department of Radiology and Medical Imaging, Foișor Clinical Hospital of Orthopaedics, Traumatology and Osteoarticular Tuberculosis, 021382 Bucharest, Romania.
- Department of Dermatology, Faculty of Medicine, Lucian Blaga University of Sibiu, 550169 Sibiu, Romania.
ORCID-Profile: Corina Porr, Emi Marinela Preda, Gabriela Mariana Iancu, Valentin-Cristian Iovin, Cosmina Diaconu
Zitieren
APA
Porr, C., Vidrighin, A., Preda, E. M., Iancu, G. M., Harris, D. M., Iovin, V. C., Catana, A. C., & Diaconu, C. (2026). Circulating Interleukin-11 Across Allergic and Non-Allergic Airway Disease Phenotypes: A Single-Center Exploratory Study. Life, 16(9), 1497. https://doi.org/10.3390/life16091497
Vancouver
Porr C, Vidrighin A, Preda EM, Iancu GM, Harris DM, Iovin VC, et al. Circulating Interleukin-11 Across Allergic and Non-Allergic Airway Disease Phenotypes: A Single-Center Exploratory Study. Life. 2026;16(9):1497. doi:10.3390/life16091497
BibTeX
@article{Porr2026,
author = {Porr, Corina and Vidrighin, Anca and Preda, Emi Marinela and Iancu, Gabriela Mariana and Harris, Dana M and Iovin, Valentin-Cristian and Catana, Alina Camelia and Diaconu, Cosmina},
title = {Circulating Interleukin-11 Across Allergic and Non-Allergic Airway Disease Phenotypes: A Single-Center Exploratory Study},
journal = {Life},
year = {2026},
volume = {16},
number = {9},
pages = {1497},
doi = {10.3390/life16091497}
}
EUVIMED